Jennie R Lill

6PUBLICATIONS
61CO-AUTHORS
Molecular targetsEpigenetics (incl. genome methylation and epigenomics)Haematological tumoursMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 26, 2024
ATF6 Promotes Colorectal Cancer Growth and Stemness by Regulating the Wnt Pathway.

Jeffrey J Rodvold, Matthew Grimmer, Karen Ruiz

|Mar 16, 2021
Discovery of a caspase cleavage motif antibody reveals insights into noncanonical inflammasome function.

Christopher W Davies, Irma Stowe, Qui T Phung

|Feb 19, 2021
Activation of NF-κB and p300/CBP potentiates cancer chemoimmunotherapy through induction of MHC-I antigen presentation.

Yixuan Zhou, Ingmar Niels Bastian, Mark D Long

|Apr 30, 2020
Development of a therapeutic anti-HtrA1 antibody and the identification of DKK3 as a pharmacodynamic biomarker in geographic atrophy.

Irene Tom, Victoria C Pham, Kenneth J Katschke

|Apr 22, 2018
Tumor suppressor BAP1 is essential for thymic development and proliferative responses of T lymphocytes.

Teresita L Arenzana, Steve Lianoglou, Akiko Seki

|Apr 20, 2017
The kinase TPL2 activates ERK and p38 signaling to promote neutrophilic inflammation.

Kate Senger, Victoria C Pham, Eugene Varfolomeev

Pageof 1